科研速递论坛

标题: LB0001 Baricitinib, an Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients... [打印本页]

作者: 翔子 时间: 2016-9-21 14:27
标题: LB0001 Baricitinib, an Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients...

题名	LB0001 Baricitinib, an Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and An Inadequate Response to CDMARD Therapy: Results of the Phase 3 RA-Build Study
链接	http://ard.bmj.com/content/74/Suppl_2/79.2

Ann Rheum Dis 2015;74:79 doi:10.1136/annrheumdis-2015-eular.6539

作者: scofiedys 时间: 2016-9-21 14:27

文件下载地址：
http://disk.680.com/NVBFVv

作者: scofiedys 时间: 2016-9-21 14:30

文件下载地址：
http://disk.680.com/NVBFVv

作者: scofiedys 时间: 2016-9-21 14:32

文件下载地址：
http://disk.680.com/NVBFVv

欢迎光临科研速递论坛 (http://expaper.cn/)